What does CUSIP 23282W605 represent in this 13F holders report?

CUSIP 23282W605 is the security identifier for CYTK - CYTOKINETICS INC - Common Stock used to aggregate holder disclosures.

How many institutions held CYTK - CYTOKINETICS INC - Common Stock in Q1 2021?

185 institutional investors reported CYTK - CYTOKINETICS INC - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

CYTOKINETICS INC - Common Stock (CYTK)

CUSIP: 23282W605

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 123,263,762
Total 13F shares: 74,824,822
Share change: +1,929,303
Total reported value: $1,739,406,944
Put/Call ratio: 53%
Price per share: $23.26
Number of holders: 185
Value change: +$58,909,832
Number of buys: 89
Number of sells: 76

Quarterly Holders Quick Answers

What is CUSIP 23282W605?
CUSIP 23282W605 identifies CYTK - CYTOKINETICS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 23282W605:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CYTK - CYTOKINETICS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	9.4%	11,611,079	$241,277,000	—	31 Dec 2020	13F
BVF INC/IL	13F	Company	4%	4,878,035	$101,366,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	3.9%	4,821,989	$100,202,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	3.8%	4,640,923	$96,438,000	—	31 Dec 2020	13F
Polar Capital Holdings Plc	13F	Company	2.7%	3,271,884	$67,990,000	—	31 Dec 2020	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	2.6%	3,226,567	$67,048,000	—	31 Dec 2020	13F
WASATCH ADVISORS LP	13F	Company	2.1%	2,555,740	$53,108,000	—	31 Dec 2020	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	2%	2,461,000	$51,140,000	—	31 Dec 2020	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	1.9%	2,400,000	$49,872,000	—	31 Dec 2020	13F
Boxer Capital, LLC	13F	Company	1.7%	2,100,000	$43,638,000	—	31 Dec 2020	13F
Marshall Wace North America L.P.	13F	Company	1.7%	2,067,868	$42,970,000	—	31 Dec 2020	13F
RTW INVESTMENTS, LP	13F	Company	1.6%	2,000,000	$41,311,000	—	31 Dec 2020	13F
Foresite Capital Management IV, LLC	13F	Company	1.2%	1,435,992	$29,840,000	—	31 Dec 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.95%	1,176,795	$24,455,000	—	31 Dec 2020	13F
Point72 Asset Management, L.P.	13F	Company	0.95%	1,166,294	$24,236,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.86%	1,055,561	$21,934,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	0.84%	1,037,571	$21,561,000	—	31 Dec 2020	13F
PFM Health Sciences, LP	13F	Company	0.79%	971,151	$20,181,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.73%	894,677	$18,591,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.72%	884,954	$18,389,000	—	31 Dec 2020	13F
RP Management, LLC	13F	Company	0.71%	875,656	$18,196,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.68%	837,457	$17,403,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.67%	823,764	$17,118,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.61%	754,100	$15,670,000	—	31 Dec 2020	13F
Vivo Capital, LLC	13F	Company	0.57%	700,000	$14,546,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.56%	687,312	$14,282,000	—	31 Dec 2020	13F
BNP Paribas Asset Management Holding S.A.	13F	Company	0.52%	635,086	$13,197,000	—	31 Dec 2020	13F
Opaleye Management Inc.	13F	Company	0.47%	582,800	$12,111,000	—	31 Dec 2020	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	0.45%	555,684	$11,547,000	—	31 Dec 2020	13F
Integral Health Asset Management, LLC	13F	Company	0.43%	525,000	$10,910,000	—	31 Dec 2020	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.42%	517,015	$10,743,000	—	31 Dec 2020	13F
Sofinnova Investments, Inc.	13F	Company	0.41%	508,394	$10,564,000	—	31 Dec 2020	13F
Artal Group S.A.	13F	Company	0.41%	500,000	$10,390,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.37%	458,182	$9,522,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.36%	443,028	$9,206,000	—	31 Dec 2020	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.34%	419,853	$8,725,000	—	31 Dec 2020	13F
S.c.a. Candriam	13F	Individual	0.3%	375,853	$7,811,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.3%	369,204	$7,672,000	—	31 Dec 2020	13F
PINNACLE ASSOCIATES LTD	13F	Company	0.29%	359,724	$7,475,000	—	31 Dec 2020	13F
CM Management, LLC	13F	Company	0.26%	325,000	$6,754,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.24%	301,176	$6,259,000	—	31 Dec 2020	13F
South Dakota Investment Council	13F	Company	0.24%	299,098	$6,215,000	—	31 Dec 2020	13F
Burrage Capital Management LLC	13F	Company	0.2%	246,036	$5,113,000	—	31 Dec 2020	13F
HHLR ADVISORS, LTD.	13F	Company	0.19%	230,718	$4,794,000	—	31 Dec 2020	13F
Ikarian Capital, LLC	13F	Company	0.18%	227,000	$4,718,000	—	31 Dec 2020	13F
Legal & General Group Plc	13F	Company	0.16%	200,498	$4,166,000	—	31 Dec 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.16%	198,679	$4,129,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.15%	188,760	$3,923,000	—	31 Dec 2020	13F
BARCLAYS PLC	13F	Company	0.15%	185,332	$3,851,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.13%	157,902	$3,281,000	—	31 Dec 2020	13F

Institutional Holders of CYTOKINETICS INC - Common Stock (CYTK) as of Q1 2021

As of 31 Mar 2021, CYTOKINETICS INC - Common Stock (CYTK) was held by 185 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 74,824,822 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, FMR LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Marshall Wace North America L.P., Polar Capital Holdings Plc, WASATCH ADVISORS INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and Farallon Capital Management, L.L.C.. This page lists 185 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

174

Q1 2021 holders

185

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.